What are the common metastatic sites for primary bone cancers, and how should I monitor for these in follow-up care?

Common metastatic sites for primary bone cancers include the lungs, other bones, and less commonly the brain. The lungs are the most frequent site of metastasis for primary bone sarcomas such as osteosarcoma and Ewing sarcoma.

Monitoring for metastases during follow-up care should involve regular clinical review and imaging tailored to the common metastatic sites. Chest imaging (such as chest X-ray or CT scan) is essential to detect pulmonary metastases early. Bone metastases can be monitored using plain radiography, MRI, or bone scintigraphy, especially for axial skeleton involvement or if symptoms suggest new lesions. MRI is preferred if other imaging is equivocal or if there is concern about spinal canal involvement. Routine brain imaging is not standard unless neurological symptoms develop, given the lower incidence of brain metastases from primary bone cancers.

Follow-up schedules should balance the need for early detection of metastases with the burden of frequent imaging on patients and healthcare resources. Clinical assessment should be prompt if new symptoms arise, with appropriate imaging arranged accordingly.

This approach aligns with NICE guidance on metastatic disease monitoring, which recommends imaging based on the most common metastatic sites and symptomatology, and highlights the importance of patient-centred care in follow-up planning.

Summary:

• Lungs are the most common metastatic site for primary bone cancers.
• Use chest imaging regularly to monitor for lung metastases.
• Use bone imaging (X-ray, MRI, bone scan) to monitor for bone metastases.
• Brain imaging only if neurological symptoms develop.
• Follow-up should be individualized to patient needs and resource considerations.

²,³